Cornerstone Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Cornerstone Advisors, LLC

$2.51 Billion
Q3 2024

A detailed history of Cornerstone Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 13,000 shares of VRTX stock, worth $6.53 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

13,000

Previous 12,200 6.56%

Holding current value

$6.53 Million

Previous $5.72 Million 5.74%

% of portfolio

0.24%

Previous 0.23%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$460.0 - $505.78 $368,000 - $404,624	800 Added 6.56%	13,000 $6.05 Million
Q2 2024 Aug 09, 2024	SELL	$392.81 - $485.53 $39,281 - $48,553	-100 Reduced 0.81%	12,200 $5.72 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $1.65 Million - $1.97 Million	-4,800 Reduced 28.07%	12,300 $5 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $2.1 Million - $2.25 Million	-6,200 Reduced 26.61%	17,100 $5.95 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $1.04 Million - $1.16 Million	3,300 Added 16.5%	23,300 $8.2 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2 Million - $2.25 Million	-7,000 Reduced 25.93%	20,000 $5.78 Million
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $1.17 Million - $1.46 Million	5,000 Added 22.73%	27,000 $7.61 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $1.69 Million - $1.99 Million	9,000 Added 69.23%	22,000 $4.44 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $1.45 Million - $1.69 Million	-7,000 Reduced 35.0%	13,000 $2.79 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $1.58 Million - $2.07 Million	7,000 Added 53.85%	20,000 $5.81 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $2.6 Million - $3.22 Million	13,000 New	13,000 $3.09 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Vertex Pharmaceuticals Inc Transaction History